Jaime Mendoza
Psychiatric/Mental Health · Maryville, ILNPI 1689915811
Payments from drug & device makers
Across 630 payments — averaging $176.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$60K
- Axsome Therapeutics, Inc.$39K
- AbbVie$6K
- Supernus Pharmaceuticals, Inc.$828
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$818
- Johnson & Johnson$718
- plus $4K from 30 others
What the payments were for
- Consulting fees$23,95722%
- Speaking & faculty fees$67,18460%
- Travel & lodging$6,3156%
- Food & beverage$13,40512%
- Education$2540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$36,989
- Austedo XR$28,386
- AUSTEDO$14,877
- UZEDY$13,964
- VRAYLAR$4,543
- LYBALVI$814
- QELBREE$317
- VNS Therapy Symmetry Model 8103 Generator$273
- COBENFY$231
- DEXCOM G7 GSS (161)$150
- DEXCOM STELO GLUCOSE BIOSENSOR$150
- Wakix$125
- JORNAY PM$125
- VALTOCO$125
- Fanapt$125
- SPRAVATO$115
- CAPLYTA$107
- REXULTI$100
How this compares
$111,114 in reported general payments places this provider in the 95th percentile of 922 psychiatric/mental health providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 41 | $568,618 |
| Austedo XrDeutetrabenazine | 29 | $182,865 |
| CaplytaLumateperone Tosylate | 62 | $115,307 |
| VraylarCariprazine Hcl | 66 | $97,151 |
| TrintellixVortioxetine Hydrobromide | 67 | $52,241 |
| SpravatoEsketamine Hcl | 36 | $46,167 |
| AuvelityDextromethorphan Hbr/Bupropion | 37 | $43,034 |
| UzedyRisperidone | 11 | $36,674 |
| BelsomraSuvorexant | 47 | $28,509 |
| RexultiBrexpiprazole | 15 | $23,450 |
| Aripiprazole | 123 | $10,646 |
| Paliperidone ErPaliperidone | 17 | $9,940 |
| NamzaricMemantine Hcl/Donepezil Hcl | 25 | $7,347 |
| DayvigoLemborexant | 18 | $7,303 |
| Quetiapine Fumarate | 350 | $6,779 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr, Uzedy, Loxapine | $59,732 | $789,69099 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $818 | $115,30762 claims |
| AbbVieVraylar, Namzaric, Viibryd | $6,301 | $108,955102 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $153 | $52,24167 claims |
| Johnson & JohnsonSpravato | $718 | $46,16736 claims |
| Axsome Therapeutics, Inc.Auvelity | $38,886 | $43,03437 claims |
| MerckBelsomra | $43 | $28,50947 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $324 | $23,45015 claims |
| Almatica Pharma LLCSertraline Hcl | $39 | $1,848252 claims |
| Lilly USA, LLCOlanzapine | $33 | $1,76677 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 922 psychiatric/mental health providers in Illinois.
Other psychiatric/mental health in Maryville
- Jennifer TheryMaryville$83K
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$162K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
- Julie CarbrayChicago$36K
- Doris van ByssumWheaton$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.